Anupam Rasayan India
ANURAS · NSEValuation
Blended fair value using DCF and peer comparison methods.
Peer comparison
How this company stacks up against sector peers on valuation and quality metrics.
Specialty chemicals · 8 peers · sector medians shown
| Company | Mkt Cap | P/E | P/B | EV/EBITDA | ROE | Net Margin | Rev CAGR 3y |
|---|---|---|---|---|---|---|---|
Anupam Rasayan India ANURAS · you | ₹14,540 Cr | 84.6× | 4.4× | 28.7× | 5.1% | 7.2% | 13.9% |
| Sector median | — | 45.3× | 3.5× | 24.7× | 10.2% | 8.9% | 1.7% |
| Linde India LINDEINDIA | ₹58,490 Cr | 106.7× | 13.7× | 64.3× | 12.9% | 21.7% | -6.9% |
| Navin Fluorine International NAVINFLUOR | ₹35,059 Cr | 52.3× | 8.8× | 33.5× | 16.7% | 20.0% | 16.8% |
| Himadri Speciality Chemical HSCL | ₹34,271 Cr | 45.3× | 7.3× | 34.1× | 16.0% | 16.1% | 3.8% |
| Deepak Nitrite DEEPAKNTR | ₹22,820 Cr | 41.3× | 3.9× | 24.7× | 9.4% | 7.0% | -0.4% |
| Atul ATUL | ₹19,511 Cr | 28.9× | 3.1× | 19.1× | 10.9% | 10.8% | 4.9% |
| Tata Chemicals TATACHEM | ₹19,007 Cr | — | 0.9× | — | -8.9% | -13.0% | -4.6% |
| PCBL Chemical PCBL | ₹11,243 Cr | 55.1× | 2.8× | 14.2× | 4.9% | 2.4% | 12.4% |
| Jubilant Ingrevia JUBLINGREA | ₹9,931 Cr | 35.7× | 3.2× | 18.5× | 8.9% | 6.3% | -2.8% |
Anupam trades at a premium to sector peers on P/E (84.6× vs median 45.3×). The market is pricing in higher growth — worth verifying whether recent revenue trends support that expectation.
Business quality
Key profitability, efficiency, and solvency metrics.
Financial health
Piotroski F-Score, Altman Z-Score, and key solvency ratios.
Full financial data
Charts and annual statements for income, balance sheet and cash flow.
Income trend
Revenue, profit and margin trends over time.
Cash flow
Where cash comes from and where it goes.
Balance sheet
Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.
How the company is funded — equity is owners' money, debt is long-term borrowing, current liabilities are short-term obligations.